HSIC

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Distribution

Located in Melville, NY, US. Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
29.69%
EBITDA Margin TTM
7.49%
Net Margin TTM
2.95%
Earnings Per Share TTM
3.44
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Henry Schein, Inc.
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
3.4b
+200.0m
+6.3%
Gross Income
1.1b
+132.0m
+14.1%
32%
+2.2pp
+7.3%
EBITDA
256.0m
+3.0m
+1.2%
8%
-0.4pp
-4.8%
Operating Income
182.0m
-20.0m
-9.9%
5%
-1.0pp
-15.3%
Net Income
107.0m
-3.0m
-2.7%
3%
-0.3pp
-8.5%
Earnings Per Share
0.93
+0.0
+4.5%
Operating Cash Flow
-97.0m
-134.0m
-362.2%
-3%
-4.0pp
-346.6%
Free Cash Flow
-136.0m
-130.0m
-2.2k%
-4%
-3.8pp
-2.0k%
Research & Development
n/a
n/a
n/a
n/a
n/a
n/a